Navigation Links
ACORN's Oncology-focused Contract Research Organization Exceeds Projections

Accelerated Community Oncology Research Network, Inc. Surpasses 2007


MEMPHIS, Tenn., March 31 /PRNewswire/ -- The Accelerated Community Oncology Research Network, Inc. (ACORN), a national oncology clinical trial network, announced today that its Contract Research Organization (CRO) exceeded performance expectations over the past 12 months. ACORN's CRO provides the full range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. "Sponsors have embraced the strength of ACORN CRO oncology focus. We are pleased that our activity in 2007 exceeded our projections and 1st Q 2008 appears equally impressive," remarked Steve Coplon, CEO.

(Logo: )

Exclusively focused on oncology, ACORN CRO is backed by scientists and medical professionals dedicated to advancing cancer care through research. An important added strength resides in ACORN's network of community oncology researchers, specifically selected because of their commitment to oncology research and excellence in its execution. Close working relationships with demographically diverse US oncology practices result.

ACORN, Inc., a privately held company, significantly enhances the speed, accuracy, and productivity of conducting clinical research in the community oncology setting. Proactive project management with focused teams of clinical experts achieves these goals. Well-defined processes augmented by proprietary technology provide oversight and efficiencies on study functions for both pharma and participating sites.

Strong site relationships enable ACORN CRO to achieve enrollment targets within required timelines. Well-defined processes for site selection include comprehensive study-specific questionnaires, feasibility assessments, and expert evaluation of potential sites, ensuring a high probability of success for each study.

ACORN CRO project teams collaborate with sponsors and stay in close contact with investigator sites. Detailed communication, from kick-off meetings to weekly teleconferences to tracking each study ensures that sponsors are current with their study progress. Advanced technology enables comprehensive metrics reports for in-depth study status.

For additional information visit or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

Deborah D. Coble


SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
5. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
6. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
7. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
8. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
9. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
10. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
11. Low Acid Coffee Backed By Scientific Research
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):